ClinicalTrials.Veeva

Menu

Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2

University of Michigan logo

University of Michigan

Status

Enrolling

Conditions

Glaucoma
Visual Impairment
Eye Diseases

Treatments

Other: Technology enhanced eye disease detection protocol
Other: Standard optometric examination

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT06934577
1U01DP006826-01 (U.S. NIH Grant/Contract)
1 U01DP006826-01-00 (Other Identifier)
HUM00267229

Details and patient eligibility

About

To compare eye disease detection rates at a Federally Qualified Health Center between a technology-enhanced protocol and standard optometric clinical examination for three of the leading causes of blindness: glaucoma, diabetic retinopathy, and visually significant cataract.

Enrollment

900 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

• Speak English, Spanish, Arabic, Chinese, French, Hindi, Finnish, Albanian, Russian or Tagalog

Exclusion criteria

  • significant eye pain
  • sudden decrease in vision within one week
  • binocular diplopia
  • cognitive impairment
  • pregnancy
  • previously declined participation

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

900 participants in 2 patient groups

Control, standard optometric examination
Experimental group
Description:
Participants will receive usual care with an optometrist with a biomicroscopic exam at the Federally Qualified Health Center to identify eye disease.
Treatment:
Other: Standard optometric examination
Other: Technology enhanced eye disease detection protocol
Intervention, technology enhanced eye disease detection protocol
Experimental group
Description:
Participants will receive a technology enhanced eye disease detection protocol from ophthalmic technicians that includes measurements of visual function such as visual acuity, refraction, intraocular pressure, pachymetry, external eye and fundus photography, and optical coherence tomography of the macula and retinal nerve fiber layer. The optometrist at the Federally. Qualified Health Center will then use a protocol to grade the testing and identify eye disease. The results of the grading will inform whether the person receives a brief appointment with the optometrist (if no disease is detected) or an in-depth appointment with the optometrist (if there is disease detected).
Treatment:
Other: Standard optometric examination
Other: Technology enhanced eye disease detection protocol

Trial contacts and locations

1

Loading...

Central trial contact

Suzanne Winter, MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems